These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 29464976)
1. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India. Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976 [TBL] [Abstract][Full Text] [Related]
2. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients. Singh B; Bera NK; Nayak CR; Chaudhuri TK Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081 [TBL] [Abstract][Full Text] [Related]
3. Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Kelly CW; McEvoy JP; Miller BJ Schizophr Res; 2019 Jul; 209():193-197. PubMed ID: 31118157 [TBL] [Abstract][Full Text] [Related]
4. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort. Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M; Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974 [TBL] [Abstract][Full Text] [Related]
6. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences. Lee EE; Ancoli-Israel S; Eyler LT; Tu XM; Palmer BW; Irwin MR; Jeste DV Am J Geriatr Psychiatry; 2019 Jan; 27(1):21-31. PubMed ID: 30442531 [TBL] [Abstract][Full Text] [Related]
7. Role of C-reactive protein in schizophrenia: an overview. Singh B; Chaudhuri TK Psychiatry Res; 2014 May; 216(2):277-85. PubMed ID: 24565000 [TBL] [Abstract][Full Text] [Related]
8. Inflammation in psychotic disorders: a population-based study. Suvisaari J; Loo BM; Saarni SE; Haukka J; Perälä J; Saarni SI; Viertiö S; Partti K; Lönnqvist J; Jula A Psychiatry Res; 2011 Sep; 189(2):305-11. PubMed ID: 21798602 [TBL] [Abstract][Full Text] [Related]
9. Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine. Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Leinonen E Nord J Psychiatry; 2017 Feb; 71(2):89-95. PubMed ID: 27658459 [TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977 [TBL] [Abstract][Full Text] [Related]
11. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Leinonen E Psychiatry Res; 2014 Aug; 218(3):277-83. PubMed ID: 24837425 [TBL] [Abstract][Full Text] [Related]
12. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome]. Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994 [TBL] [Abstract][Full Text] [Related]
13. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set. Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M; J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214 [TBL] [Abstract][Full Text] [Related]
14. Procalcitonin and C - reactive protein as peripheral inflammatory markers in antipsychotic drug-free schizophrenia patients. Varun CN; Raju R; Venkataswamy MM; Ravi V; Varambally S Asian J Psychiatr; 2018 Jun; 35():11-14. PubMed ID: 29723719 [TBL] [Abstract][Full Text] [Related]
15. Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients. Subbanna M; Shivakumar V; Venugopal D; Narayanaswamy JC; Berk M; Varambally S; Venkatasubramanian G; Debnath M Psychiatry Clin Neurosci; 2020 Jan; 74(1):64-69. PubMed ID: 31587436 [TBL] [Abstract][Full Text] [Related]
16. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Karadag F; Kirdar S; Karul AB; Ceylan E Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305 [TBL] [Abstract][Full Text] [Related]
17. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES). Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus. Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250 [TBL] [Abstract][Full Text] [Related]
20. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia. Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]